(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) Wall Street was lower for the third straight trading day, pulled down by Microsoft, ahead of the Federal Reserve's policy meeting starting Tuesday. Dow Jones industrial average futures were down 0.40 percent at 17,794, S&P 500 futures were down 0.49 percent at 2,086 and Nasdaq 100 futures were down 0.70 percent at 4,434.5.
** LINKEDIN CORP $192.22, +46.64 pct
** MICROSOFT CORP $50.03, -2.82 pct
Microsoft agreed to buy LinkedIn Corp for $26.2 billion in its biggest-ever deal, combining the software giant’s fast-growing cloud services business with the world’s largest online network for professionals. Microsoft was the biggest drag on all three major indexes.
** TWITTER INC $14.76, +5.28 pct
Goldman adds Twitter stock to list of companies it believes have at least 15 pct chance of seeing M&A action in next one year, according to note - Bloomberg.
** SMITH & WESSON HOLDING CORP, $23.06, +7.71 pct
** STURM RUGER & CO INC, $62.5, +8.87 pct
Man armed with assault rifle pledging loyalty to Islamic State killed 50 people during a gay pride celebration at an Orlando nightclub on Sunday. Shares of the gunmakers often rise on expectations of increased sales due to fears of potential gun control policies.
** MARINUS PHARMACEUTICALS INC, $1.5187, -71.56 pct
The company said it plans to stop developing therapy for drug-resistant focal onset seizures in adults after it failed a late-stage trial
** ELEVEN BIOTHERAPEUTICS INC, $2.693, +44.01 pct
The drug developer entered into an exclusive license agreement with Swiss drugmaker Roche Holdings AG under which Roche will develop and commercialize Eleven’s eye drug
** TURQUOISE HILL RESOURCES LTD $3.33, +15.63 pct
Rio Tinto Plc has hired Goldman Sachs to increase its stake in Turquoise Hill and privatize the company, with the help of a potential strategic buyer, Sunday Times reported.
** ORASURE TECHNOLOGIES INC, $6.74, -13.37 pct
Raymond James analysts downgrade to “market perform” from “outperform”, citing competition in HIV test business, and pending decision on whether company will choose to exit its agreement with AbbVie Inc for promoting its hepatitis C test.
** BIOSCRIP INC, $2.3301, -17.66 pct
The company has offered 40 mln shares, about 58 pct of total outstanding, to fund $85 mln purchase of privately held HS Infusion Holdings.
** AGIOS PHARMACEUTICALS INC, $49.2, -2.27 pct
The drug developer presented encouraging data on lead drug, AG-348, to treat a rare inherited disease called PK deficiency, which is characterized by accelerated destruction of red blood cells, at a medical meeting on Saturday.
** PENN WEST PETROLEUM, $1.3, +41.32 pct
The company said on Friday it would sell its Saskatchewan assets, which include holdings in the Viking region, for $975 mln.
** FACEBOOK INC, $114.2, -2.08 pct
Influential short-seller Citron Research's Andrew Left says short on Facebook - CNBC. "Facebook is losing an extensive amount of relevancy," Left tells CNBC. (cnb.cx/1YlCE6x)
** APPLE INC, $97.49, -1.36 pct
The company kicked off its developer event on Monday. Apple demonstrated a ew operating system for the Apple Watch that opens apps much faster than the previous version, and lets users write messages with their finger on the watch face, including in Chinese.
** VISA INC, $78.96, -1.52 pct
Walmart Canada stores, said on Saturday, that it will stop accepting Visa cards as the credit card provider charges merchants “unacceptably high” fees.
** SKYLINE MEDICAL INC, $0.2075, +15.28 pct
The company said its FDA-approved STREAMWAY System will now be available to the U.S. Federal Government Facilities.
** SYMANTEC CORP, $18.33, +5.95 pct
The company said it would buy privately held cyber security company Blue Coat for $4.65 billion in a cash deal that will ramp up Symantec’s enterprise security business. (Compiled by Rishika Sadam in Bengaluru; Edited by Don Sebastian)